Access to and Engagement in Substance Use Disorder Treatment Over Time.


Journal

Psychiatric services (Washington, D.C.)
ISSN: 1557-9700
Titre abrégé: Psychiatr Serv
Pays: United States
ID NLM: 9502838

Informations de publication

Date de publication:
01 07 2020
Historique:
pubmed: 25 2 2020
medline: 5 5 2021
entrez: 25 2 2020
Statut: ppublish

Résumé

This study evaluated whether access to and engagement in substance use disorder treatment has improved from 2010 to 2016. Data submitted by commercial and Medicaid health plans, representing over 163 million beneficiaries from 2010 to 2016, were analyzed. For commercial plans, identification increased (from 1.0% to 1.6%, p<0.001), the initiation rate declined (from 41.9% to 33.7%, p<0.001), and the engagement rate also declined (from 15.8% to 12.1%, p<0.001). The decline in the initiation and engagement rates could not be explained by the increasing identification rates. For Medicaid plans, the identification rate increased (from 3.3% to 6.7%, p<0.001), and the initiation and engagement rates were unchanged. Although an increasing proportion of health plan members are being identified with substance use disorders, the majority of these individuals are not engaging in treatment.

Identifiants

pubmed: 32089081
doi: 10.1176/appi.ps.201800461
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

722-725

Auteurs

Junqing Liu (J)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Amy Storfer-Isser (A)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Tami L Mark (TL)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Tyler Oberlander (T)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Constance Horgan (C)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Deborah W Garnick (DW)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Sarah Hudson Scholle (SH)

National Committee for Quality Assurance, Washington, D.C. (Liu, Storfer-Isser, Oberlander, Scholle); RTI International, Washington, D.C. (Mark); Heller School for Social Policy and Management, Brandeis University, Waltham, Massachusetts (Horgan, Garnick).

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH